CoChat

Antibiotics and the Nervous System—Which Face of Antibiotic Therapy Is Real, Dr. Jekyll (Neurotoxicity) or Mr. Hyde (Neuroprotection)?

Open access
Hurkacz, Magdalena, Dobrek, Lukasz, Wiela-Hojeńska, Anna · 2021 · Molecules

The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Antibiotics as antibacterial drugs have saved many lives, but have also become a victim of their own success. Their widespread abuse reduces their anti-infective effectiveness and causes the development of bacterial resistance. Moreover, irrational antibiotic therapy contributes to gastrointestinal dysbiosis, that increases the risk of the development of many diseases, including neurological and psychiatric. One of the potential options for restoring homeostasis is the use of oral antibiotics that are poorly absorbed from the gastrointestinal tract (e.g., rifaximin alfa). Thus, antibiotic therapy may exert neurological or psychiatric adverse drug reactions which are often considered to be overlooked and undervalued issues. Drug-induced neurotoxicity is mostly observed after beta-lactams and quinolones. Penicillin may produce a wide range of neurological dysfunctions, including encephalopathy, behavioral changes, myoclonus or seizures. Their pathomechanism results from the disturbances of gamma-aminobutyric acid-GABA transmission (due to the molecular similarities between the structure of the β-lactam ring and GABA molecule) and impairment of the functioning of benzodiazepine receptors (BZD). However, on the other hand, antibiotics have also been studied for their neuroprotective properties in the treatment of neurodegenerative and neuroinflammatory processes (e.g., Alzheimer’s or Parkinson’s diseases). Antibiotics may, therefore, become promising elements of multi-targeted therapy for these entities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26247456

Cites

134 of 135 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 7

  1. Zagaria M.A.E. Antibiotic therapy: Adverse effects and dosing considerations US Pharm 2013 38 18 20
  2. Demler T.L. Drug-induced neurologic conditions US Pharm 2014 39 47 51
  3. Jain K.K. Chapter 1: Epidemiology and Clinical Significance Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 1 5
  4. Jain K.K. Chapter 2: Pathomechanisms of Drug-Induced Neurological Disorders Drug-Induced Neurological Disorders 3rd revised and expanded ed. Hogrefe Publishing Gottingen, Germany 2012 7 12
  5. File T.M. Tan J.S. Recommendations for using imipenem-cilastatindthe most broad spectrum antibiotic Hosp. Formul. 1987 22 534 542
  6. Liu X. Microbiome Yale J. Biol. Med. 2016 89 275 276
  7. Kathait J. Rawat A.S. Beta-lactam antibiotics induced neurotoxicity IOSR J. Pharm. 2020 10 1 7

Cited by

See all 64

Metadata

Authors
Hurkacz, M., Dobrek, L., & Wiela-Hojeńska, A.
Affiliations
  • Wroclaw Medical University (PL)
  • Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland
Venue
Molecules
Publisher
MDPI AG
Published
2021-12-09
Volume
26
Issue
24
Pages
7456
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4200466444
Cited by
60
References
135
Citations by year
2026: 13 · 2025: 9 · 2024: 13 · 2023: 18 · 2022: 7
FWCI
1.20
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
antibiotics, drug-induced neurotoxicity, neuroprotection, beta-lactam antibiotics, quinolones, GABA transmission, benzodiazepine receptor, antibiotic resistance, gut dysbiosis, rifaximin, Alzheimer's disease, Parkinson's disease, neuroinflammation, adverse drug reactions
MeSH terms
Neuroprotection, Animals, Anti-Bacterial Agents, Humans, Nervous System, Neuroprotective Agents, Neurotoxicity Syndromes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.